Navigation Links
Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process
Date:10/22/2008

MONTREAL, Oct. 22 /PRNewswire/ -- Global Vision, the leader in automated proofreading solutions for the pharmaceutical industry announced today that 15 of the top 20 pharmaceutical companies have selected Global Vision to help them reduce the risk of textual and artwork errors from occurring in their packaging process. The integration of automated proofreading technology has resulted in a reduction of quality issues and costs, along with speeding up product launches.

Debi Schimpf, Associate Director at Wyeth comments "Global Vision has helped us implement better methods for detecting errors before they become costly. They're extremely knowledgeable when it comes to securing the artwork packaging workflow. Over the last 10 years of working with Global Vision, we have realized significant benefits and financial savings."

In the pharmaceutical manufacturing environment, there are thousands of packaging components being produced in a multitude of languages each year. Keeping track of the accuracy of these materials is a complex and challenging undertaking. Global Vision's technology is becoming a standard way for companies to ensure that their products reach the shelves without labeling errors.

"These companies are turning to us because we can offer them a safer and simpler way to work. Our customers need to feel confident in their approval and change control process. We give them peace of mind, along with the added benefits of decreased approval times and significant cost savings," says President Reuben Malz.

Global Vision is committed to providing solutions to ensure that all aspects of the packaging process are accurate. Global Vision has recently integrated Braille inspection capabilities into all its solutions in compliance with the recent EMEA regulations that require Braille on labels and cartons.

All systems meet EMEA and FDA 21 CFR Part 11 requirements.

About Global Vision

Global Vision provides automated proofreading solutions that enable organizations to achieve unprecedented content integrity. Major pharmaceutical companies rely on Global Vision to reduce the risk of textual or artwork errors from occurring throughout their workflow. For over a decade, Global Vision has helped clients increase inspection accuracy, speed, productivity, and process efficiencies. More information is available at http://www.globalvisioninc.com .


'/>"/>
SOURCE Global Vision, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project
2. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
3. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
4. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
5. Mentice Appoints Bjorn Larsson as Vice President of Global Marketing
6. International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive
7. The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria
8. Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
9. Kendle to Present at the UBS Global Life Sciences Conference
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Boston Scientific to Participate in UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):